Respiratory Molecular Diagnostic Solutions
Discover fast, accurate, and simple respiratory testing for your patients
Decentralizing PCR testing with GeneXpert® technology, including our comprehensive respiratory tests, facilitates system-wide standardization, providing patient and caregiver accessibility to fast, accurate, and reliable diagnostics across the continuum of patient care.
Our diagnostic tests cater to modern healthcare needs, offering quick and accurate detection of infections like Strep A, Flu A/B, COVID-19, and RSV. Utilizing advanced molecular diagnostic techniques, Cepheid ensures exceptional sensitivity and specificity, so you can trust the results you obtain.
Why Choose Cepheid?
Empower healthcare providers, enhance patient care, and revolutionize your practice with our cutting-edge technology. Explore our full range of tests and discover our unwavering commitment to quality and innovation.
- Accurate Results: Trustworthy RT-PCR diagnostics for confident decisions.
- Fast Turnaround: Get quick results for timely treatment.
- User-Friendly: Easy-to-use systems that streamline workflows.
- Innovative Technology: Leading molecular diagnostics that can be used in the lab or in CLIA-waived environments.
Choose real-time PCR testing for your patients.
Connect with us today!
Xpert® Xpress Strep A
Delivers accurate and timely results that optimizes fast treatment decisions.
- Cepheid provides on-demand testing for Group A Strep in as soon as 18 minutes.*
- Careful selection of the target gene produces quality results.
- Delivering accurate and timely results optimizes fast treatment decisions and eliminates the need to perform culture confirmation of negative results.
Xpert® Xpress CoV-2 plus^
Designed with 3 gene targets for a rapid, robust detection of SARS-CoV-2. The Xpert Xpress CoV-2 plus test provides:
- Fast and accurate results in as early as 20 minutes.*
- Three gene targets for SARS-CoV-2 as well as an optimization of SARS-CoV-2 probes to enable more realizable virus detection.
- Rapid sample-to-answer testing with actionable results from a single sample.
Xpert® Xpress CoV-2/Flu/RSV plus^
4-in-1 real-time on-demand PCR testing solution for the respiratory season:
- Multiplex test intended for the simultaneous in vitro qualitative detection and differentiation of CoV-2, influenza A, influenza B, and RSV.
-
Provides fast and accurate results in as early as 25 minutes* for SARS-CoV-2.
-
Utilizes a multi-gene target approach for the detection of SARS-CoV-2 and influenza providing target redundancy to mitigate the potential impact of genetic shift and drift on strain detection.
The Answer is Simpler: PCR vs EIA
Better answers lead to better outcomes – not all technologies are created equal. Discover how it’s Simpler with Cepheid.
Standardizing Practice On a Single Platform- Pediatrician Testimonial
Dr. Dov Shapiro talks about testing platform standardization at his practice. Learn how multiplex PCR testing can be a valuable differentiator for your care.
Ready to speak with a member of our team?
US-IVD. In Vitro Diagnostic Medical Device. May not be available in all countries.
* With Early Assay Termination (EAT) for positive results.
^ These tests have not been FDA cleared or approved. These tests have been authorized by FDA under an EUA for use by authorized laboratories; Xpert® Xpress CoV-2 plus has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens. Xpert® Xpress CoV-2/Flu/RSV plus has been authorized only for the simultaneous qualitative detection and differentiation of nucleic acids from SARS-CoV-2, Infuenza A, Infuenza B, and respiratory syncytial virus (RSV), and not for any other viruses or pathogens. This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. §360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.
About Cepheid
Cepheid is dedicated to improving healthcare by pioneering molecular diagnostics that combine speed, accuracy, and flexibility. The company's GeneXpert® systems and Xpert® tests automate highly complex and time-consuming manual procedures, providing A Better Way for institutions of any size to perform world-class PCR testing. Cepheid's broad test portfolio spans respiratory infections, blood virology, women's and sexual health, TB and emerging infectious diseases, healthcare-associated infectious diseases, oncology and human genetics. The company's solutions deliver actionable results where they are needed most from central laboratories and hospitals to near patient settings.
For more information, visit www.cepheid.com
904 Caribbean Drive, Sunnyvale, CA 94089
©2025 Cepheid. All Rights Reserved.